Healthcare provider profile · identity verified

Bridget K. Lenz, MD

Family Practice · MUKWONAGO, WI · NPI 1366521510

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	496	138
Levothyroxine Sodium	Levothyroxine Sodium	310	83
Lisinopril	Lisinopril	291	83
Losartan Potassium	Losartan Potassium	273	68
Amlodipine Besylate	Amlodipine Besylate	265	72
Pantoprazole Sodium	Pantoprazole Sodium	215	50
Gabapentin	Gabapentin	205	48
Rosuvastatin Calcium	Rosuvastatin Calcium	177	49
Omeprazole	Omeprazole	171	52
Sertraline Hcl	Sertraline Hcl	159	41
Metoprolol Succinate	Metoprolol Succinate	156	45
Hydrochlorothiazide	Hydrochlorothiazide	141	42
Metformin Hcl Er	Metformin Hcl	141	42
Alprazolam	Alprazolam	140	39
Simvastatin	Simvastatin	135	35
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	131	28
Furosemide	Furosemide	123	38
Metformin Hcl	Metformin Hcl	119	29
Eliquis	Apixaban	117	20
Zolpidem Tartrate	Zolpidem Tartrate	104	21
Venlafaxine Hcl Er	Venlafaxine Hcl	102	13
Pravastatin Sodium	Pravastatin Sodium	100	27
Atenolol	Atenolol	94	25
Escitalopram Oxalate	Escitalopram Oxalate	93	20
Metoprolol Tartrate	Metoprolol Tartrate	90	16
Duloxetine Hcl	Duloxetine Hcl	84	16
Albuterol Sulfate Hfa	Albuterol Sulfate	81	38
Clopidogrel	Clopidogrel Bisulfate	81	20
Fluoxetine Hcl	Fluoxetine Hcl	81	19
Bupropion Xl	Bupropion Hcl	80	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	71	20
Alendronate Sodium	Alendronate Sodium	70	23
Amitriptyline Hcl	Amitriptyline Hcl	68	14
Potassium Chloride	Potassium Chloride	67	20
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	65	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	59	18
Tamsulosin Hcl	Tamsulosin Hcl	56	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	55	suppressed
Ozempic	Semaglutide	54	13
Tramadol Hcl	Tramadol Hcl	52	11
Buspirone Hcl	Buspirone Hcl	51	suppressed
Rybelsus	Semaglutide	51	suppressed
Trazodone Hcl	Trazodone Hcl	51	18
Glipizide Er	Glipizide	50	14
Spironolactone	Spironolactone	49	14
Lorazepam	Lorazepam	44	16
Carvedilol	Carvedilol	43	13
Ezetimibe	Ezetimibe	43	suppressed
Glimepiride	Glimepiride	42	12
Lovastatin	Lovastatin	42	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	41	suppressed
Montelukast Sodium	Montelukast Sodium	40	14
Warfarin Sodium	Warfarin Sodium	39	suppressed
Citalopram Hbr	Citalopram Hydrobromide	37	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	35	suppressed
Allopurinol	Allopurinol	34	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	33	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	13
Fluticasone Propionate	Fluticasone Propionate	32	11
Ondansetron Hcl	Ondansetron Hcl	31	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	suppressed
Methylprednisolone	Methylprednisolone	29	24
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	18
Pregabalin	Pregabalin	26	suppressed
Famotidine	Famotidine	24	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Donepezil Hcl	Donepezil Hcl	23	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	23	suppressed
Nystatin	Nystatin	23	14
Oxycodone Hcl	Oxycodone Hcl	23	suppressed
Glipizide	Glipizide	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Estradiol	Estradiol	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	12
Lansoprazole	Lansoprazole	19	suppressed
Amoxicillin	Amoxicillin	18	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	15
Enalapril Maleate	Enalapril Maleate	16	suppressed
Meloxicam	Meloxicam	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	14
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Diazepam	Diazepam	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Butalb-Acetaminoph-Caff-Codein	Butalbit/Acetamin/Caff/Codeine	14	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	14	12
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Topiramate	Topiramate	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Baclofen	Baclofen	12	suppressed
Butalbital-Aspirin-Caffeine	Butalbital/Aspirin/Caffeine	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Flecainide Acetate	Flecainide Acetate	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Jardiance	Empagliflozin	12	suppressed
Premarin	Estrogens, Conjugated	12	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	12	suppressed
Valsartan	Valsartan	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Prednisone	Prednisone	11	11
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error